Universal screening for novel coronavirus disease 2019 (COVID‐19) for asymptomatic parturients: May not be beneficial at this time

Henderson, Cassandra E.; Rezai, Shadi; Jackman, Janelle M.

doi:10.1002/jmv.26507

Cited by 4 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, these tests have limitations, such as the time required to perform them and the presence of false negative results of more than 30% ( 1 ), particularly when those tested are in the early stages of infection and/or asymptomatic. Given that asymptomatic patients have been shown to account for up to 80% of those infected ( 2 ), and yet can transmit the virus ( 3 ), tests need to provide rapid results with sufficient sensitivity and specificity to inform prevention and social isolation measures. The use of rapid diagnostic tests that primarily detect the virus antigen has been widely implemented in practice as an effective strategy to provide a prompt result in a matter of minutes.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Diagnostic Strategies for Identifying SARS-CoV-2 Infection in Clinical Practice: a Systematic Review and Compliance with the Standards for Reporting Diagnostic Accuracy Studies Guideline (STARD)

et al. 2022

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Evaluation of Diagnostic Strategies for Identifying SARS-CoV-2 Infection in Clinical Practice: a Systematic Review and Compliance with the Standards for Reporting Diagnostic Accuracy Studies Guideline (STARD)

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Additionally, the false negative rate for some tests is known to be up to 30% and false positives also occur due to cross-reactivity with other Coronaviruses. ( 11 ) This creates several pitfalls associated with universal testing. First, false negative results can lead to a false sense of reassurance among healthcare workers and lapses in personal protective equipment compliance.…”

Section: Discussionmentioning

confidence: 99%

The impact of confirmed coronavirus disease 2019 (COVID-19) infection on ambulatory procedures and associated delays in care for asymptomatic patients

Larsen

Bub

Schaffler

et al. 2021

Surgery

View full text Add to dashboard Cite

Background: Since the reopening of ambulatory centers, minimal data has been reported regarding positive tests among patients undergoing ambulatory procedures, associated delays in care, and outcomes of patients previously positive for coronavirus disease 2019. Methods: A retrospective observational case series of ambulatory procedures was performed. Records since the reopening of ambulatory centers in New York were searched for patients with positive coronavirus disease 2019 nasal swab results who underwent ambulatory procedures. Chart reviews were conducted to determine coronavirus disease history and hospitalizations, demographic information, procedure details, and 30-day admissions. Results: A total of 3,762 patients underwent ambulatory procedures. Of those, 53 were previously diagnosed with coronavirus disease 2019 but recovered and tested negative at preprocedural testing. Of the 3,709 asymptomatic patients, 37 (1.00%) tested positive during preprocedural testing; 21 patients had their procedures delayed on average 28.6 days until testing negative, while 16 had their procedures performed before testing negative owing to the time sensitivity of the procedure. There were no major complications or 30-day admissions in any of these asymptomatic patients. Three patients tested positive for coronavirus disease after having an ambulatory procedure. Conclusion: Positive tests in asymptomatic patients led to procedure delays of 28.6 days. No patients who underwent ambulatory procedures after a positive coronavirus disease 2019 test had any coronavirus disease-related complications, regardless of whether or not the procedure was delayed until testing negative. Three patients tested positive for coronavirus disease 2019 after having an ambulatory procedure; however, at an average of 19.7 days after, these cases were likely community acquired making the rate of nosocomial infection negligible.

show abstract

“…Because the cesarean section is associated with risks for the mother, and on the other hand, babies born to infected mothers are often in good condition [97]. There is no increase in anomalies in children born to affected mothers [98,99]. Also, the rate of stillbirth and intrauterine death is similar to that of the noninfected population [19,100].…”

Section: Labor and Deliverymentioning

confidence: 99%

Pregnancy, peripartum, and COVID-19: An updated literature review

et al. 2022

View full text Add to dashboard Cite

Due to the physiological changes of the pregnancy and considering the susceptibility of the fetus, pregnant women are among the vulnerable health groups. The current COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has multiplied the health burden on vulnerable and susceptible groups. With over 500,000 new cases daily, the vulnerable groups are in danger more than ever. Therefore, early diagnosis, effective treatment, and efficient prevention strategies are significant among these groups. Since the clinical knowledge about the diagnosis, management, prevention, and many other aspects of pregnancy and lactation during COVID-19 has significantly changed and improved from the pandemic's beginning, most of the previous knowledge has changed, and the previous publications might not be helpful anymore. This review aims to provide an updated and comprehensive review of the mutual impact of pregnancy and COVID-19 infection, discuss the current controversies based on the most recent findings, and highlight the existing knowledge gaps. Due to the increased susceptibility, undesired outcomes are more expected among pregnant women with COVID-19 infection. Still, prevention measures are the best way of managing COVID-19 in this population. Moreover, further clinical studies should address the long-term complications, outcomes, safety of vaccination, and the impact of the pandemic on mental health.

show abstract

Universal screening for novel coronavirus disease 2019 (COVID‐19) for asymptomatic parturients: May not be beneficial at this time

Cited by 4 publications

References 6 publications

Evaluation of Diagnostic Strategies for Identifying SARS-CoV-2 Infection in Clinical Practice: a Systematic Review and Compliance with the Standards for Reporting Diagnostic Accuracy Studies Guideline (STARD)

Evaluation of Diagnostic Strategies for Identifying SARS-CoV-2 Infection in Clinical Practice: a Systematic Review and Compliance with the Standards for Reporting Diagnostic Accuracy Studies Guideline (STARD)

The impact of confirmed coronavirus disease 2019 (COVID-19) infection on ambulatory procedures and associated delays in care for asymptomatic patients

Pregnancy, peripartum, and COVID-19: An updated literature review

Contact Info

Product

Resources

About